Could a single infusion of supercharged immune cells tame incurable autoimmune diseases?
NCT ID NCT07038447
First seen Jan 06, 2026 · Last updated May 01, 2026 · Updated 19 times
Summary
This early-phase study is testing a new treatment called KITE-363 for people with severe autoimmune diseases like lupus, scleroderma, and inflammatory myopathy that haven't improved with standard therapies. KITE-363 uses a patient's own immune cells, which are modified in a lab to target and destroy faulty immune cells causing the disease. The goal is to see if this approach is safe and can reduce disease activity, potentially allowing patients to stop or reduce other medications, though lifelong management may still be needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope
Duarte, California, 91010, United States
-
Concord Repatriation General Hospital
Sydney, New South Wales, 2139, Australia
-
Jewish General Hospital
Montreal, H3T1E2, Canada
-
St Vincent's Hospital
Fitzroy, Victoria, 3065, Australia
-
Stanford University
Stanford, California, 94305, United States
-
The Ottawa Hospital, General Campus
Ottawa, K1H 8L6, Canada
Conditions
Explore the condition pages connected to this study.